Research from various laboratories worldwide has demonstrated that the tri-peptide GHK-Cu offers multiple biological effects, such as promoting wound healing, attracting immune cells, reducing inflammation and oxidative stress, and facilitating the production of collagen and glycosaminoglycan in skin cells while promoting blood vessel growth
Researchers use these models to understand how BPC-157 might mitigate mucosal damage, promote ulcer healing, and maintain the integrity of the gastrointestinal epithelial barrier
The February 2026 strategic alliance between eNavvi and ACHC (the Accreditation Commission for Health Care, which administers PCAB accreditation) was designed specifically to address this quality gap
Healthy weight loss maintenance with exercise, liraglutide, or both combined
The human clinical trial gap: As of this writing, no published randomized, placebo-controlled human clinical trial has evaluated BPC-157 for any indication
